SCHEMBL23224726

SCHEMBL23224726

c1ccc(-c2ccc(N(c3cccc(-c4ccc5ccccc5c4)c3)c3cccc4c3-c3ccccc3C4(c3ccccc3)c3ccccc3)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 1/20 0.33
▸ HSD17B2 P37059 1/20 0.33
▸ ESR1 P03372 3/20 0.31
▸ ESR2 Q92731 3/20 0.31
▸ CHRNA1 P02708 1/20 0.31
▸ CHRNG P07510 1/20 0.31
▸ CHRNB1 P11230 1/20 0.31
▸ CHRNB2 P17787 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31
▸ CHRNB4 P30926 1/20 0.31
▸ SLC6A4 P31645 1/20 0.31
▸ CHRNA3 P32297 1/20 0.31
▸ CHRNA4 P43681 1/20 0.31
▸ SLC6A3 Q01959 1/20 0.31
▸ CHRND Q07001 1/20 0.31
▸ HDAC4 P56524 1/20 0.30
▸ HDAC2 Q92769 1/20 0.30
▸ HDAC8 Q9BY41 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26001343 1.00 HSD17B1 (0.33) HSD17B1HSD17B2ESR1ESR2CHRNA1
SCHEMBL26001488 1.00 HSD17B1 (0.33) HSD17B1HSD17B2ESR1ESR2CHRNA1
SCHEMBL26001341 1.00 HSD17B1 (0.33) HSD17B1HSD17B2ESR1ESR2CHRNA1
SCHEMBL26001486 1.00 HSD17B1 (0.33) HSD17B1HSD17B2ESR1ESR2CHRNA1
SCHEMBL24771767 1.00 HSD17B1 (0.33) HSD17B1HSD17B2ESR1ESR2CHRNA1
SCHEMBL26001632 1.00 HSD17B1 (0.33) HSD17B1HSD17B2ESR1ESR2CHRNA1
SCHEMBL24815004 1.00 HSD17B1 (0.33) HSD17B1HSD17B2ESR1ESR2CHRNA1
SCHEMBL24771685 1.00 HSD17B1 (0.33) HSD17B1HSD17B2ESR1ESR2CHRNA1
SCHEMBL23180818 0.99 HSD17B1 (0.32) HSD17B1HSD17B2ESR1ESR2CHRNA1
SCHEMBL24842166 0.99 HSD17B1 (0.32) HSD17B1HSD17B2ESR1ESR2CHRNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed
US-20220399501-A1 ORGANIC LIGHT-EMITTING ELEMENT LG CHEM, LTD. (KR) 2022-12-15 — — US disclosed
WO-2021070965-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220399501-A1 ORGANIC LIGHT-EMITTING ELEMENT CYP1A1, AHR, CYP1B1 HSD17B1 776/4885HSD17B2 843/4885ESR1 512/4885
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, PIEZO1 HSD17B1 2196/4885HSD17B2 2389/4885ESR1 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback